Supply-chain vulnerabilities in critical medicines: A persistent risk to pharmaceutical security.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 40875843.
- Also identified by DOI 10.1126/science.adx0871.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Asymmetries in the global supply chain expose countries to systemic vulnerabilities that require investment in visibility, coordination, and resilience.
Medical subject headings
- Drug Industry
- Drugs, Essential